3',4'-dihydroxyflavone has been researched along with 2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-one in 2 studies
Studies (3',4'-dihydroxyflavone) | Trials (3',4'-dihydroxyflavone) | Recent Studies (post-2010) (3',4'-dihydroxyflavone) | Studies (2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-one) | Trials (2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-one) | Recent Studies (post-2010) (2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-one) |
---|---|---|---|---|---|
31 | 0 | 14 | 8 | 0 | 5 |
Protein | Taxonomy | 3',4'-dihydroxyflavone (IC50) | 2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-one (IC50) |
---|---|---|---|
Telomerase reverse transcriptase | Homo sapiens (human) | 0.324 | |
Polyphenol oxidase 2 | Agaricus bisporus | 0.07 | |
Bromodomain-containing protein 4 | Homo sapiens (human) | 0.204 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.74 | |
Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | 0.74 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballinari, D; Bargiotti, A; Bonomini, L; Ceccarelli, W; D'Alessio, R; Fretta, A; Menichincheri, M; Moll, J; Polucci, P; Soncini, C; Tibolla, M; Trosset, JY; Vanotti, E | 1 |
Hong, C; Jeong, S; Kim, KH; Lee, J; Park, T | 1 |
2 other study(ies) available for 3',4'-dihydroxyflavone and 2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-one
Article | Year |
---|---|
Catecholic flavonoids acting as telomerase inhibitors.
Topics: Antineoplastic Agents; Catechols; Flavones; Humans; Structure-Activity Relationship; Telomerase | 2004 |
3-Hydroxychromones as cyclin-dependent kinase inhibitors: synthesis and biological evaluation.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Chromones; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor Proteins; Humans; Inhibitory Concentration 50; Protein Binding; Structure-Activity Relationship | 2007 |